Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 23, 2001
Grant Date -
N/A
app pub date -
Apr 7, 2000
filing date -
Apr 9, 1999
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
An injectable slow-release naltrexone formulation is provided comprising naltrexone in a poly(D,L-lactide) matrix with a small amount of residual ethyl acetate. Upon intramuscular injection of the composition, naltrexone is released in a controlled manner over an extended period of time. The composition finds use in the treatment of heroin addicts and alcoholics to reduce consumption of the abused substances.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully